Clinical Trials Browser

Completed × LY2940680 × Clear all

NCT05199584 2026-03-05

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

CNSDermatologicEndocrineHead & NeckOther solid neoplasmSarcomaThoracic

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

NCT01226485 2019-09-13

A Study in Advanced Cancer

Phase 1 Completed

84 enrolled 22 charts

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT01919398 2019-09-11

A Study of LY2940680 in Japanese Participants With Advanced Cancers

Phase 1 Completed

19 enrolled 13 charts

Tumor-Agnostic

Neoplasm Metastasis